Top Medical News
brain and med
Kanas Chan, 4 days ago
Long-acting injectable antipsychotics (LAIAs) showed no substantial advantage over oral antipsychotics in terms of time to discontinuation in patients with early-phase schizophrenia, the EULAST trial has demonstrated.
elderly having medicine
Kanas Chan, 5 days ago
The overall rate of antipsychotic drug prescriptions to patients with dementia increased markedly during the initial months of the COVID-19 pandemic, and did not return to prepandemic levels when the acute phase was over, a multinational network cohort study has shown.
Autism spectrum disorders linked to cardiometabolic diseases
5 days ago
Children with autism spectrum disorders are at increased risk of diabetes, dyslipidaaemia, and heart disease, according to a study.
Online on par with in-person care for improving outcomes in psoriasis
26 Jan 2023
An online health model appears to be as effective as in-person care for decreasing functional impairment and depressive symptoms in patients with psoriasis, according to a study.
Asthma may up risk of hospitalization in kids with COVID-19
17 Jan 2023
Individuals with asthma may benefit from a behavioural intervention to increase their physical activity (PA), which may lead to improvements in quality of life and sleep, as well as a reduction in asthma and anxiety symptoms, suggest the results of a recent study.
CVD, mood disorders up risk of dementia in RA patients
Stephen Padilla, 17 Jan 2023
Among patients with rheumatoid arthritis (RA), those with clinically active RA, cardiovascular or cerebrovascular disease (CVD), hypertension, depression, and anxiety are at greater risk of dementia, reveals a study. Among CVD events, ischaemic stroke and heart failure are significantly associated with an increased dementia risk.
Original New Drug Application Approvals by US FDA (01-15 January 2023)
17 Jan 2023
New drug applications approved by US FDA as of 01-15 January 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Conference Reports
Young cyberbullying victims at heightened risk of self-harm
Jairia Dela Cruz, 24 May 2021
For children, being at the receiving end of online bullying makes them 12 times more susceptible to suicidal thoughts and actions, with the risk exacerbated by increased use of social media, as shown in the results of a meta-analysis presented at the virtual American Psychiatric Association (APA) 2021 Annual Meeting.
Bright light therapy at midday: Does it help in bipolar depression?
Elvira Manzano, 07 May 2021
Bright light therapy done at midday may be an effective and affordable adjunct to antimanic medication in patients with bipolar depression (BD), according to an expert who presented at APA 2021. This brings renewed attention to this natural, somatic treatment primarily used for seasonal depression.
Anxiety in MCI may lead to Alzheimer’s disease
Roshini Claire Anthony, 01 Jan 2021

Anxiety symptoms in patients with mild cognitive impairment (MCI) may increase their risk of developing Alzheimer’s disease, according to a study presented at the Radiological Society of North America annual meeting (RSNA 2020).

Multidomain intervention effective for dementia prevention
Dr. Joseph Delano Fule Robles, 28 Nov 2018

Multidomain intervention which includes nutrition, exercise, cognitive training and vascular risk monitoring is effective in preventing dementia, findings from the FINGER study have shown.

Ginkgo biloba extract improves cognition and overall condition after ischaemic stroke
Christina Lau, 23 Nov 2018

Use of a ginkgo biloba extract on top of standard preventive treatment is shown to improve cognitive function and overall condition after acute ischaemic stroke.